Literature DB >> 9396009

Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function.

H Varoqui1, J D Erickson.   

Abstract

Neurotransmission depends on the regulated release of chemical transmitter molecules. This requires the packaging of these substances into the specialized secretory vesicles of neurons and neuroendocrine cells, a process mediated by specific vesicular transporters. The family of genes encoding the vesicular transporters for biogenic amines and acetylcholine have recently been cloned. Direct comparison of their transport characteristics and pharmacology provides information about vesicular transport bioenergetics, substrate feature recognition by each transporter, and the role of vesicular amine storage in the mechanism of action of psychopharmacologic and neurotoxic agents. Regulation of vesicular transport activity may affect levels of neurotransmitter available for neurosecretion and be an important site for the regulation of synaptic function. Gene knockout studies have determined vesicular transport function is critical for survival and have enabled further evaluation of the role of vesicular neurotransmitter transporters in behavior and neurotoxicity. Molecular analysis is beginning to reveal the sites involved in vesicular transporter function and the sites that determine substrate specificity. In addition, the molecular basis for the selective targeting of these transporters to specific vesicle populations and the biogenesis of monoaminergic and cholinergic synaptic vesicles are areas of research that are currently being explored. This information provides new insights into the pharmacology and physiology of biogenic amine and acetylcholine vesicular storage in cardiovascular, endocrine, and central nervous system function and has important implications for neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396009     DOI: 10.1007/BF02740633

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  178 in total

Review 1.  Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles.

Authors:  J P Henry; D Scherman
Journal:  Biochem Pharmacol       Date:  1989-08-01       Impact factor: 5.858

2.  Increase in rat brain acetylcholine induced by choline or deanol.

Authors:  D R Haubrich; P F Wang; D E Clody; P W Wedeking
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

3.  Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.

Authors:  D Peter; T Vu; R H Edwards
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

Review 4.  Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane.

Authors:  J P Henry; B Gasnier; M P Roisin; M F Isambert; D Scherman
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 5.  Molecular biology of the vesicular ACh transporter.

Authors:  T B Usdin; L E Eiden; T I Bonner; J D Erickson
Journal:  Trends Neurosci       Date:  1995-05       Impact factor: 13.837

Review 6.  Protein targeting in the neuron.

Authors:  R B Kelly; E Grote
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

Review 7.  The brain cholinergic system in ageing mammals.

Authors:  G Pepeu; F Casamenti; I M Pepeu; C Scali
Journal:  J Reprod Fertil Suppl       Date:  1993

8.  Necropsy evidence of central cholinergic deficits in senile dementia.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

9.  Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.

Authors:  M J Nirenberg; J Chan; Y Liu; R H Edwards; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

Review 10.  Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.

Authors:  L S Seiden; K E Sabol
Journal:  NIDA Res Monogr       Date:  1996
View more
  22 in total

1.  Ca2+ sensitivity of synaptic vesicle dopamine, gamma-aminobutyric acid, and glutamate transport systems.

Authors:  P P Gonçalves; S M Meireles; P Neves; M G Vale
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  Identification of endophilins 1 and 3 as selective binding partners for VGLUT1 and their co-localization in neocortical glutamatergic synapses: implications for vesicular glutamate transporter trafficking and excitatory vesicle formation.

Authors:  Stephanie De Gois; Elisabeth Jeanclos; Marie Morris; Sukhjeevan Grewal; Helene Varoqui; Jeffrey D Erickson
Journal:  Cell Mol Neurobiol       Date:  2006-05-19       Impact factor: 5.046

3.  Identification of the differentiation-associated Na+/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses.

Authors:  Helene Varoqui; Martin K H Schäfer; Heming Zhu; Eberhard Weihe; Jeffrey D Erickson
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

4.  Discovery of novel antigiardiasis drug candidates.

Authors:  Liudmila Kulakova; Andrey Galkin; Catherine Z Chen; Noel Southall; Juan J Marugan; Wei Zheng; Osnat Herzberg
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

5.  Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice.

Authors:  E R Travis; Y M Wang; D J Michael; M G Caron; R M Wightman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 6.  Localization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.

Authors:  Martin K-H Schafer; Eberhard Weihe; Lee E Eiden
Journal:  Adv Pharmacol       Date:  2013

7.  Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

Authors:  F Fumagalli; R R Gainetdinov; Y M Wang; K J Valenzano; G W Miller; M G Caron
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

8.  Search for the acetylcholine and vesamicol binding sites in vesicular acetylcholine transporter: the region around the lumenal end of the transport channel.

Authors:  Parul Khare; Anuprao Mulakaluri; Stanley M Parsons
Journal:  J Neurochem       Date:  2010-10-12       Impact factor: 5.372

9.  Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.

Authors:  Anthony Raffo; Kolbe Hancock; Teresa Polito; Yuli Xie; Gordon Andan; Piotr Witkowski; Mark Hardy; Pasquale Barba; Caterina Ferrara; Antonella Maffei; Matthew Freeby; Robin Goland; Rudolph L Leibel; Ian R Sweet; Paul E Harris
Journal:  J Endocrinol       Date:  2008-07       Impact factor: 4.286

10.  The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.

Authors:  J S Duerr; D L Frisby; J Gaskin; A Duke; K Asermely; D Huddleston; L E Eiden; J B Rand
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.